TuisYPHDF • OTCMKTS
add
Ypsomed Holding AG
Vorige sluiting
$392,02
Jaarwisseling
$362,28 - $535,75
Markkapitalisasie
4,45 mjd CHF
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
SWX
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CHF) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 181,34 m | 11,94% |
Bedryfskoste | -8,52 m | -120,75% |
Netto inkomste | 69,55 m | 326,67% |
Netto winsgrens | 38,35 | 281,21% |
Wins per aandeel | — | — |
EBITDA | 102,22 m | 132,33% |
Effektiewe belastingkoers | 5,55% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CHF) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 36,30 m | -30,61% |
Totale bates | 1,21 mjd | 2,35% |
Totale aanspreeklikheid | 401,49 m | -28,19% |
Totale ekwiteit | 807,19 m | — |
Uitstaande aandele | 13,65 m | — |
Prys om te bespreek | 6,63 | — |
Opbrengs op bates | 17,29% | — |
Opbrengs op kapitaal | 25,58% | — |
Kontantvloei
Netto kontantverandering
| (CHF) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 69,55 m | 326,67% |
Kontant van bedrywe | 65,19 m | 94,90% |
Kontant van beleggings | 78,74 m | 222,01% |
Kontant van finansiering | -143,68 m | -791,74% |
Netto kontantverandering | -97,00 k | 99,11% |
Beskikbare kontantvloei | -3,03 m | 91,47% |
Meer oor
Ypsomed Holding Inc. is a Swiss multinational medical technology company headquartered in Burgdorf, Switzerland. Founded in 2003, through the break up of Disetronic Group, founded by Willy Michel. Ypsomed specializes in developing and manufacturing injection and infusion systems for self-medication, primarily in the areas of diabetes care and biotechnology.
Products include devices like insulin pens, auto-injectors, and infusion pumps, which help patients manage chronic conditions more easily and independently. In 2025, Ypsomed employs 2,800+ employees and has an annual turnover of 728.9 million Swiss Francs. The company is listed on SIX Swiss Exchange. Wikipedia
HUB
Gestig
2003
Webwerf
Werknemers
2 000
